Skip to main content

Advertisement

SpringerLink
Log in

Coronary Artery Diseases in South Asian Immigrants: An Update on High Density Lipoprotein Role in Disease Prevention

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript

Abstract

Over the past several years, the overall prevalence and incidence of cardiovascular diseases (CVD) including coronary artery diseases (CAD) have declined in the United States (US) and in many developed countries. However, among South Asian in general and South Asian immigrants (SAIs) in particular, a disturbing trend toward high rates of CAD has been noted. This trend is associated with a high prevalence of conventional risk factors and metabolic syndrome in this population, yet these conventional risk factors may not account for the greater CAD risk among SAIs. A search for additional markers is warranted, to enable early detection and prevention of CAD in this high risk group. High density lipoprotein (HDL) is one of the predictor of CAD and is considered to be cardio-protective. However, some of the recent studies have shown that HDL is not only ineffective as an antioxidant but, paradoxically, appears to be pro-oxidant, and has been found to be associated with CAD. Such HDL is called dysfunctional HDL. We present here an overview CAD and CAD risk factors in general and dyslipidemias in particular in SAIs. In addition, the evolving theories on dysfunctional HDL and its impact on CAD are also briefly presented.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998;97:596–601.

    PubMed  CAS  Google Scholar 

  2. Uppaluri CR. Heart disease and its related risk factors in Asian Indians. Ethn Dis. 2002;12(1):45–53.

    PubMed  Google Scholar 

  3. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. J Am Med Assoc. 2007;297(3):286–94. doi:10.1001/jama.297.3.286.

    Article  CAS  Google Scholar 

  4. Reddy KS. Cardiovascular diseases in non-Western countries. N Engl J Med. 2004;350:2438–40. doi:10.1056/NEJMp048024.

    Article  PubMed  CAS  Google Scholar 

  5. Nordlie MA, Wold LE, Kloner RA. Genetic contributors toward increased risk for ischemic heart disease. J Mol Cell Cardiol. 2005;39(4):667–79. doi:10.1016/j.yjmcc.2005.06.006.

    Article  PubMed  CAS  Google Scholar 

  6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of diseases, part 1: general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation. 2001;104:2746–53. doi:10.1161/hc4601.099487.

    Article  PubMed  CAS  Google Scholar 

  7. Enas EA, Garg A, Davidson MA, et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J. 1996;48(4):343–53.

    PubMed  CAS  Google Scholar 

  8. Enas EA, Mehta J. Malignant coronary artery disease in young Asian Indians: thoughts on pathogenesis, prevention, and treatment. Clin Cardiol. 1995;18(3):131–5.

    Article  PubMed  CAS  Google Scholar 

  9. Anand SS, Yusuf S, Vuksan V, et al. Difference in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet. 2000;356:279–84. doi:10.1016/S0140-6736(00)02502-2.

    Article  PubMed  CAS  Google Scholar 

  10. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases, part II: variations in cardiovascular diseases by specific ethnic groups and geographic and prevention strategies. Circulation. 2001;104:2855–64. doi:10.1161/hc4701.099488.

    Article  PubMed  CAS  Google Scholar 

  11. Murray CJL, Lopez AD. Global health statistics, global burden of disease and injury series. Boston, Mass: Harvard School of Public Health; 1996.

    Google Scholar 

  12. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124(3):235–44.

    PubMed  Google Scholar 

  13. Klatsky AL, Tekawa I, Armstrong MA, et al. The risk of hospitalization for ischemic heart disease among Asian Americans in northern California. Am J Public Health. 1994;84(10):1672–75.

    Article  PubMed  CAS  Google Scholar 

  14. Bhatnagar D, Anand IS, Durrington PN, et al. Coronary risk factors in people from the Indian subcontinent living in West London and their siblings in India. Lancet. 1995;345:405–9.

    Article  PubMed  CAS  Google Scholar 

  15. Williams B. Westernized Asians and cardiovascular disease: nature or nurture. Lancet. 1995;345:401–2. doi:10.1016/S0140-6736(95)90394-1.

    Article  PubMed  CAS  Google Scholar 

  16. Petersen S, Peto V, Rayner M Coronary heart disease statistics, British Heart Foundation, London (2004). Available at http://www.heartstats.org/datapage.asp?id=1652.

  17. Bedi US, Singh S, Syed A, Aryafar H, Arora R. Coronary artery disease in South Asians: an emerging risk group. Cardiol Rev. 2006;14(2):74–80. doi:10.1097/01.crd.0000182411.88146.72.

    Article  PubMed  Google Scholar 

  18. Grundy SM. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002;105:2696–8. doi:10.1161/01.CIR.0000020650.86137.84.

    Article  PubMed  Google Scholar 

  19. Kuppuswamy VC, Gupta S. Excess coronary heart disease in South Asians in the United Kingdom. BMJ. 2005;330(7502):1223–4. doi:10.1136/bmj.330.7502.1223.

    Article  PubMed  Google Scholar 

  20. Tillin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia. 2005;48(4):649–56. doi:10.1007/s00125-005-1689-3.

    Article  PubMed  CAS  Google Scholar 

  21. Forouhi N, McKeigue P. How far can risk factors account for excess coronary mortality in South Asians? Can J Cardiol. 1997;13(Suppl B):47B.

    Google Scholar 

  22. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk factors explain the higher coronary heart disease mortality in South Asian compared with European men? Prospective follow-up of the Southall and Brent studies. Diabetologia. 2006;49(11):2580–8. doi:10.1007/s00125-006-0393-2.

    Article  PubMed  CAS  Google Scholar 

  23. McGovern PG, Pankow JS, Shahar E, Doliszny KM, Folsom AR, Blackburn H, et al. The Minnesota heart survey investigators. Recent trends in acute coronary heart disease-mortality, morbidity, medical care, and risk factors. N Engl J Med. 1996;334:884–90. doi:10.1056/NEJM199604043341403.

    Article  PubMed  CAS  Google Scholar 

  24. Luepker RV, Arnett DK, Jacobs DR Jr, Duval SJ, Folsom AR, Armstrong C, et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota heart survey. Am J Med. 2006;119(1):42–9. doi:10.1016/j.amjmed.2005.08.051.

    Article  PubMed  Google Scholar 

  25. Vizza J, Neatrour DM, Felton PM, Ellsworth DL. Improvement in psychosocial functioning during an intensive cardiovascular lifestyle modification program. J Cardiopulm Rehabil Prev. 2007;27(6):376–83.

    PubMed  Google Scholar 

  26. Khunti K, Stone MA, Bankart J, Sinfield P, Pancholi A, Walker S, et al. Primary prevention of type-2 diabetes and heart disease: action research in secondary schools serving an ethnically diverse UK population. J Public Health (Oxf). 2008;30(1):30–7. doi:10.1093/pubmed/fdm078.

    Article  CAS  Google Scholar 

  27. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air force/texas coronary atherosclerosis prevention study. J Am Med Assoc. 1998;279:1615–22. doi:10.1001/jama.279.20.1615.

    Article  CAS  Google Scholar 

  28. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with Simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360:7–22.

    Article  Google Scholar 

  29. Enas EA. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc. 2000;98(11):694–5, 697–702.

    Google Scholar 

  30. Kuller LH, Velentgas P, Barzilay J, Beauchamp NJ, O’Leary DH, Savage PJ. Diabetes mellitus: sub-clinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol. 2000;20(3):823–9.

    PubMed  CAS  Google Scholar 

  31. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N. 34th Bethesda conference: task force #1-identification of coronary heart disease risk: is there a detection gap? J Am Coll Cardiol. 2003;41(11):1863–74. doi:10.1016/S0735-1097(03)00358-9.

    Article  PubMed  Google Scholar 

  32. Devine PJ, Carlson DW, Taylor AJ. Clinical value of carotid intima-media thickness testing. J Nucl Cardiol. 2006;13(5):710–8. doi:10.1016/j.nuclcard.2006.07.007.

    Article  PubMed  Google Scholar 

  33. Patel SN, Rajaram V, Pandya S, Fiedler BM, Bai CJ, Neems R, et al. Emerging, noninvasive surrogate markers of atherosclerosis. Curr Atheroscler Rep. 2004;6(1):60–8. doi:10.1007/s11883-004-0117-3.

    Article  PubMed  Google Scholar 

  34. Smith SC, Greenland P, Grundy SM. Prevention conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Executive summary. Circulation. 2000;101:111–6.

    PubMed  Google Scholar 

  35. Rosa EM, Kramer C, Castro I. Association between coronary artery atherosclerosis and the intima-media thickness of the common carotid artery measured on ultrasonography. Arq Bras Cardiol. 2003;80(6):589–92, 285–8.

    Google Scholar 

  36. Dodani S, Kaur R, Reed GL, George V, Sharma G, Marion L. The association of carotid intima media thickness with dysfunctional HDL in South Asians. Arch Med Sci. 2008;4(1):40–6.

    Google Scholar 

  37. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128(4):262–9.

    PubMed  CAS  Google Scholar 

  38. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke. 1997;28(6):1189–94.

    PubMed  CAS  Google Scholar 

  39. O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med. 1999;340(1):14–22. doi:10.1056/NEJM199901073400103.

    Article  PubMed  Google Scholar 

  40. Geroulakos G, O’Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J. 1994;15(6):781–5.

    PubMed  CAS  Google Scholar 

  41. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96(5):1432–7.

    PubMed  CAS  Google Scholar 

  42. Granér M, Varpula M, Kahri J, Salonen RM, Nyyssönen K, Nieminen MS, et al. Association of carotid intima-media thickness with angiographic severity and extent of coronary artery disease. Am J Cardiol. 2006;97(5):624–9. doi:10.1016/j.amjcard.2005.09.098.

    Article  PubMed  Google Scholar 

  43. Adams MR, Nakagomi A, Keech A, Robinson J, McCredie R, Bailey BP, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92(8):2127–34.

    PubMed  CAS  Google Scholar 

  44. Feder G, Crook AM, Magee P, Banerjee S, Timmis AD, Hemingway H. Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography. BMJ. 2002;324(7336):511–6. doi:10.1136/bmj.324.7336.511.

    Article  PubMed  Google Scholar 

  45. Farooqi A, Nagra D, Edgar T, Khunti K. Attitudes to lifestyle risk factors for coronary heart disease amongst South Asians in Leicester: a focus group study. Fam Pract. 2000;17(4):293–7. doi:10.1093/fampra/17.4.293.

    Article  PubMed  CAS  Google Scholar 

  46. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease four prospective American studies. Circulation. 1989;79:8–15.

    PubMed  CAS  Google Scholar 

  47. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin survival study (4S). Lancet. 1994;344:1383–9.

    Google Scholar 

  48. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1350–1.

    Article  Google Scholar 

  49. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285:2486–97.

    Article  Google Scholar 

  50. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism. 2001;50(10):1197–202. doi:10.1053/meta.2001.26704.

    Article  PubMed  CAS  Google Scholar 

  51. Hoogeveen RC, Gambhir JK, Gambhir DS, Kimball KT, Ghazzaly K, Gaubatz JW, et al. Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts. J Lipid Res. 2001;42(4):631–8.

    PubMed  CAS  Google Scholar 

  52. D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. J Am Med Assoc. 2001;286(2):180–7. doi:10.1001/jama.286.2.180.

    Article  Google Scholar 

  53. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to newcastle heart project data. J Public Health. 2005;27(1):93–100. doi:10.1093/pubmed/fdh202.

    Article  Google Scholar 

  54. Ballantyne CM, Hoogeveen RC. Role of lipid and lipoprotein profiles in risk assessment and therapy. Am Heart J. 2003;146(2):227–33. doi:10.1016/S0002-8703(02)94701-0 Review.

    Article  PubMed  CAS  Google Scholar 

  55. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. J Am Med Assoc. 1986;256:2835–8. doi:10.1001/jama.256.20.2835.

    Article  CAS  Google Scholar 

  56. Yancey PG, Bortnick AE, Kellner-Weibel G, et al. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thomb Vasc Biol. 2003;23:712–9.

    Article  CAS  Google Scholar 

  57. Williams DL, Connelly MA, Temel RE, Swarnakar S, Phillips MC, et al. Scavenger receptor B1 and cholesterol trafficking. Curr Opin Lipidol. 1999;10:329–39. doi:10.1097/00041433-199908000-00007.

    Article  PubMed  CAS  Google Scholar 

  58. Takahashi Y, Smith JD. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci United States Am. 1999;96:11358–63. doi:10.1073/pnas.96.20.11358.

    Article  CAS  Google Scholar 

  59. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, et al. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter. Biochem Biophys Res Commun. 2001;280:818–23. doi:10.1006/bbrc.2000.4219.

    Article  PubMed  CAS  Google Scholar 

  60. Mackness MI, Arrol S, Abbott C, Durrington PN. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 1993;104:129–35.

    Article  PubMed  CAS  Google Scholar 

  61. Marathe GK, Zimmerman GA, McIntyre TM. Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. J Biol Chem. 2002;278:3937–47.

    Article  PubMed  Google Scholar 

  62. Navab M, Berliner JA, Subbanagounder G, et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Arterioscler Thromb Vasc Biol. 2001;21(5):880.

    Google Scholar 

  63. Graham A, Hassall DJ, Rafique S, Owen JS. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Atherosclerosis. 1997;135:193–204.

    Article  PubMed  CAS  Google Scholar 

  64. Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Jin L, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1. J Lipid Res. 2000;41:1481–94.

    PubMed  CAS  Google Scholar 

  65. Navab M, Hama SY, Anantharamaiah GM, Hassan K, Hough GP, Watson AD, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res. 2000;41:1495–508.

    PubMed  CAS  Google Scholar 

  66. Barter PJ, Baker PW, Rye KA. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol. 2002;13:285–8. doi:10.1097/00041433-200206000-00008.

    Article  PubMed  CAS  Google Scholar 

  67. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Mechanisms of disease: proatherogenic HDL—an evolving field. Nat Clin Pract Endocrinol Metab. 2006;2(9):504–11. doi:10.1038/ncpendmet0245.

    Article  PubMed  CAS  Google Scholar 

  68. Ansell BJ, Fonarow GC, Fogelman AM. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep. 2006;8(5):405–11. doi:10.1007/s11883-006-0038-4.

    Article  PubMed  CAS  Google Scholar 

  69. Ansell BJ, Fonarow GC, Fogelman AM. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005;46(10):1792–8. doi:10.1016/j.jacc.2005.06.080.

    Article  PubMed  CAS  Google Scholar 

  70. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, et al. The double jeopardy of HDL. Ann Med. 2005;37(3):173–8. doi:10.1080/07853890510007322.

    Article  PubMed  CAS  Google Scholar 

  71. Fogelman AM. When good cholesterol goes bad. Nat Med. 2004;10(9):902–3. doi:10.1038/nm0904-902.

    Article  PubMed  CAS  Google Scholar 

  72. Zheng L, Nukuna B, Brennan ML, et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest. 2004;114:529–41.

    PubMed  CAS  Google Scholar 

  73. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, et al. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Curr Opin Lipidol. 2004;15(6):645–9. doi:10.1097/00041433-200412000-00004.

    Article  PubMed  CAS  Google Scholar 

  74. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogelman AM. A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J Lipid Res. 2001;42:1308–17.

    PubMed  CAS  Google Scholar 

  75. Ansell BJ, Navab N, Hama S, et al. Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by Simvastatin treatment. Circulation. 2003;108:2751–6. doi:10.1161/01.CIR.0000103624.14436.4B.

    Article  PubMed  CAS  Google Scholar 

  76. Dodani S, Dong YB, Zhu H, George V. Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants? Indian J Hum Genet. 2008;4(1):9–15.

    Article  Google Scholar 

  77. Watson KE, Ansell BJ, Watson AD, Fonarow GC. HDL function as a target of lipid-modifying therapy. Rev Cardiovasc Med. 2007;8(1):1–8. doi:10.1016/j.carrev.2007.01.003.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical College of Georgia, EC 4503 Health Sciences Building, 997 St Sebastian Way, Augusta, GA, 30812, USA

    Sunita Dodani

Authors
  1. Sunita Dodani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunita Dodani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dodani, S. Coronary Artery Diseases in South Asian Immigrants: An Update on High Density Lipoprotein Role in Disease Prevention. J Immigrant Minority Health 11, 415–421 (2009). https://doi.org/10.1007/s10903-008-9183-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10903-008-9183-x

Keywords

Search

Navigation